Comparison of Four Rapid N-Glycan Analytical Methods and Great Application Potential in Cell Line Development
Source abstract
Abstract
N-glycan, a critical quality attribute (CQA) of monoclonal antibodies, profoundly impacts potency, immunogenicity, safety, and clinical efficiency. Therefore, N-glycan should be monitored and controlled during development. The conventional 2-AB method is considered the gold standard for N-glycan analysis, which is labor intensive and time consuming. Moreover, its sample requirement is relatively high and cannot be met in early-stage development, including cell line development. In this study, we compared the performance of four rapid analytical methods in N-glycan analysis of mAbs, including the rapid 2-AB method, reduction method, off-line IdeS digestion method, and two-dimensional liquid chromatography-mass spectrometry (2D-LC-MS) method. Our results showed that these four rapid analytical methods could provide comparable N-glycan data. Moreover, these four rapid methods shortened the testing time for the conventional 2-AB method from days to just minutes. They also reduced the sample requirement for the conventional 2-AB method from milligrams to micrograms. Among these four rapid methods, the 2D-LC-MS method demonstrated great potential for applications in time-consuming cell line development because it required less testing time and a lower sample requirement.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Glycosylation and Glycoproteins Research · Protein purification and stability · Monoclonal and Polyclonal Antibodies Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, China
School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, China
Funding
National Key Research and Development Program of China · Jiangsu Synergetic Innovation Center for Advanced Bio-Manufacture
References (33)
Show source-provided references
1. Yaozhi (2024, February 22). Top10 Best-Selling Drugs in 2023. Available online: https://m.baidu.com/bh/m/detail/ar_9971613961676379877.
2. Trends in industrialization of biotherapeutics: A survey of product characteristics of 89 antibody-based biotherapeutics10.1080/19420862.2023.2191301 ↗
3. Current advances in biopharmaceutical informatics: Guidelines, impact and challenges in the computational developability assessment of antibody therapeutics10.1080/19420862.2021.2020082 ↗
4. Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&D10.1080/19420862.2020.1754999 ↗
5. N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins10.1016/j.ejpb.2016.01.005 ↗
6. N-Glycosylation of monoclonal antibody therapeutics: A comprehensive review on significance and characterization10.1016/j.aca.2022.339828 ↗
7. Comparing different domains of analysis for the characterisation of N-glycans on monoclonal antibodies10.1016/j.jpha.2019.11.008 ↗
8. N-Glycosylation of IgG and IgG-Like Recombinant Therapeutic Proteins: Why Is It Important and How Can We Control It?10.1146/annurev-chembioeng-102419-010001 ↗
9. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G110.1016/j.jmb.2007.02.034 ↗
10. Orthogonal Assessment of Biotherapeutic Glycosylation: A Case Study Correlating N-Glycan Core Afucosylation of Herceptin with Mechanism of Action10.1021/acs.analchem.6b02994 ↗
11. Galactosylation variations in marketed therapeutic antibodies10.4161/mabs.19868 ↗
12. Fc-galactosylation modulates antibody-dependent cellular cytotoxicity of therapeutic antibodies10.1016/j.molimm.2016.03.002 ↗
13. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans10.1093/glycob/cwr027 ↗
14. Effect of high mannose glycan pairing on IgG antibody clearance10.1016/j.biologicals.2016.02.003 ↗
15. Characterization of glycosylation in monoclonal antibodies and its importance in therapeutic antibody development10.1080/07388551.2020.1869684 ↗
16. Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications10.1016/j.aca.2019.08.044 ↗
17. Eckard, A.D., Dupont, D.R., and Young, J.K. (2018). Development of Two Analytical Methods Based on Reverse Phase Chromatographic and SDS-PAGE Gel for Assessment of Deglycosylation Yield in N-Glycan Mapping. Biomed. Res. Int., 2018.10.1155/2018/3909674 ↗
18. A novel mammalian cell line development platform utilizing nanofluidics and optoelectro positioning technology10.1002/btpr.2690 ↗
19. High-throughput screening of antibody-expressing CHO clones using an automated shaken deep-well system10.1002/btpr.2721 ↗
20. The sweet spot for biologics: Recent advances in characterization of biotherapeutic glycoproteins10.1080/14789450.2018.1404907 ↗
21. Kaur, H., and Reusch, D. (2021). Monoclonal Antibodies Physicochemical Analysis, Elsevier Inc.
22. Development of a 3D-LC/MS Workflow for Fast, Automated, and Effective Characterization of Glycosylation Patterns of Biotherapeutic Products10.1021/acs.analchem.9b05193 ↗
23. Marquet, F., D’Atri, V., Guillarme, D., and Borchard, G. (2022). A New Practice to Monitor the Fabrication Process of Fab-Targeting Ligands from Bevacizumab by LC-MS: Preparation and Analytical Characterization. Sci. Pharm., 90.10.3390/scipharm90010005 ↗
24. In-Depth Characterization of mAb Charge Variants by On-Line Multidimensional Liquid Chromatography-Mass Spectrometry10.1021/acs.analchem.3c00791 ↗
25. Charge variant analysis of protein-based biopharmaceuticals using two-dimensional liquid chromatography hyphenated to mass spectrometry10.1016/j.chroma.2020.461786 ↗
26. Agilent (2019, July 01). Agilent AdvanceBio Gly-X N-Glycan Prep with 2-AB Express Kit. Available online: https://www.agilent.com.cn/cs/library/usermanuals/public/5994-1228EN.pdf.
27. Developability assessment during the selection of novel therapeutic antibodies10.1002/jps.24430 ↗
28. A review of two-dimensional liquid chromatography approaches using parallel column arrays in the second dimension10.1016/j.aca.2022.340300 ↗
29. Rautenberg, T.A., Ng, S.K.A., and Downes, M. (2023). A cross-sectional study of symptoms and health-related quality of life in menopausal-aged women in China. BMC Womens Health, 23.10.1186/s12905-023-02728-y ↗
30. Someya, T., Kasahara, M., Takemoto, S., and Hattori, M. (2023). The Wear Behavior of Glass-Ceramic CAD/CAM Blocks against Bovine Enamel. Materials, 16.10.3390/ma16216839 ↗
31. The Cosine Similarity Technique: A new method for smart EXCIMER laser control10.1016/j.zemedi.2020.02.006 ↗
32. Direct comparison of derivatization strategies for LC-MS/MS analysis of N-glycans10.1039/C7AN01262D ↗
33. Comparison of Traditional 2-AB Fluorescence LC-MS/MS and Automated LC-MS for the Comparative Glycan Analysis of Monoclonal Antibodies10.1002/jps.24522 ↗